Biology of the estrogen receptor, GPR30, in triple negative breast cancer

American Journal of Surgery

Volumn 206, Issue 5, 2013, Pages 698-703

  Steiman, Jennifer ^a   Peralta, Elizabeth A ^a,b   Louis, Somaja ^a   Kamel, Onsi ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sutter Medical Group of the Redwoods Sutter Pacific Medial Foundation   (United States)

Author keywords

Estrogen receptor; G protein coupled receptor; Prognosis; Triple negative breast cancer

Indexed keywords

ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH;

EID: 84886698168     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.07.014     Document Type: Review

References (23)

1. J.Q. Chen, and J. Russo ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Biochim Biophys Acta 1796 2009 162 175
2. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429 4434
3. H.G. Kaplan, and J.A. Malmgren Impact of triple negative phenotype on breast cancer prognosis Breast J 14 2008 456 463
4. M. Shastry, and D.A. Yardley Updates in the treatment of basal/triple-negative breast cancer Curr Opin Obstet Gynecol 25 2013 40 48
5. K.B. Reddy Triple-negative breast cancers: an updated review on treatment options Curr Oncol 18 2011 e173 e179
6. N. Turner, A. Tutt, and A. Ashworth Hallmarks of "BRCAness" in sporadic cancers Nat Rev Cancer 4 2004 814 819
7. C.M. Perou, T. Sørlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
8. A. Prat, B. Adamo, and M.C. Cheang Molecular characterization of basal-like and non-basal-like triple-negative breast cancer Oncologist 18 2013 123 133
9. B.D. Lehmann, J.A. Bauer, and X. Chen Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Invest 121 2011 2750 2767
10. C. Carmeci, D.A. Thompson, and H.Z. Ring Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer Genomics 45 1997 607 617
11. E.R. Prossnitz, J.B. Arterburn, and H.O. Smith Estrogen signaling through the transmembrane G protein-coupled receptor GPR30 Annu Rev Physiol 70 2008 165 190
12. E.J. Filardo, C.T. Graeber, and J.A. Quinn Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression Clin Cancer Res 12 2006 6359 6366
13. P. Thomas, Y. Pang, and E.J. Filardo Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 2005 624 632
14. E.J. Filardo Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer J Steroid Biochem Mol Biol 80 2002 231 238
15. L. Albanito, D. Sisci, and S. Aquila Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells Endocrinology 149 2008 3799 3808
16. R. Girgert, G. Emons, and C. Gründker Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy Breast Cancer Res Treat 134 2012 199 205
17. T.R. Rebbeck, H.T. Lynch, and S.L. Neuhausen Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622
18. A. Vivacqua, D. Bonofiglio, and L. Albanito 17β-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30 Mol Pharmacol 70 2006 1414 1423
19. E.W. Lapensee, T.R. Tuttle, and S.R. Fox Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells Environ Health Perspect 117 2009 175 180
20. E.J. Filardo, and P. Thomas Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology Endocrinology 153 2012 2953 2962
21. C.I. Li, J.R. Daling, and P.L. Porter Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer Cancer Res 69 2009 6865 6870
22. D. Filmore It's a GPCR world Modern Drug Disc 7 2004 24 28
23. M.M. Litwiniuk, K. Roznowski, and V. Filas Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers BMC Cancer 8 2008 100